Filing Details

Accession Number:
0001179110-22-002278
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-03-16 16:29:33
Reporting Period:
2022-03-14
Accepted Time:
2022-03-16 16:29:33
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
926326 Omnicell Inc OMCL Electronic Computers (3571) 943166458
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1736895 Peter Scott Seidelmann 590 E. Middlefield Road
Mountain View CA 94043
Evp, Chief Commercial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-03-14 19,040 $0.00 53,140 No 4 A Direct
Common Stock Disposition 2022-03-14 2,235 $131.21 50,905 No 4 F Direct
Common Stock Disposition 2022-03-16 2,525 $133.11 48,380 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 F Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 43,620 Direct
Footnotes
  1. Reflects performance-based restricted stock units that were previously granted on February 9, 2021 subject to the Company meeting certain stock performance objectives compared to the NASDAQ Healthcare Index, as previously reported at the target amount of 9,520 shares on Form 4 filed on February 11, 2021. On March 14, 2022 (the determination date), the Compensation Committee determined the performance criteria was met with respect to 19,040 performance-based restricted stock units (200% of target) of which 25% vested upon the determination date. The remaining performance-based restricted stock units will vest on a semi-annual basis over a period of thirty-six months commencing on June 15, 2022.
  2. Reflects withholding of shares to cover taxes due in connection with the vesting of performance-based restricted stock units.
  3. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9,2021.
  4. The price reported in Column 4 is an exact price of $133.11 for all shares sold.